O’Melveny represented TYK Medicines in the transaction.TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong Stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
